Pacific Biosciences
PACB
PACB
226 hedge funds and large institutions have $395M invested in Pacific Biosciences in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 68 increasing their positions, 77 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
226
Holders Change
-1
Holders Change %
-0.44%
% of All Funds
3.27%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
24
Increased
68
Reduced
77
Closed
24
Calls
$3.32M
Puts
$3.63M
Net Calls
-$312K
Net Calls Change
+$308K
Top Buyers
| 1 |
Millennium Management
New York
|
+$9.85M |
| 2 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$6.07M |
| 3 |
Jane Street
New York
|
+$1.64M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.55M |
| 5 |
Morgan Stanley
New York
|
+$1.38M |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.2M |
| 2 |
Bank of New York Mellon
New York
|
-$7.42M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$4.4M |
| 4 |
D.E. Shaw & Co
New York
|
-$2.25M |
| 5 |
VS
VK Services
Menlo Park,
California
|
-$2.24M |
